0000899243-21-012695.txt : 20210318 0000899243-21-012695.hdr.sgml : 20210318 20210318213924 ACCESSION NUMBER: 0000899243-21-012695 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210316 FILED AS OF DATE: 20210318 DATE AS OF CHANGE: 20210318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEVIN ARTHUR A CENTRAL INDEX KEY: 0001181556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39321 FILM NUMBER: 21756329 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avidity Biosciences, Inc. CENTRAL INDEX KEY: 0001599901 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461336960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-401-7900 MAIL ADDRESS: STREET 1: 10975 N. TORREY PINES RD., STREET 2: #150 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Avidity Biosciences LLC DATE OF NAME CHANGE: 20161227 FORMER COMPANY: FORMER CONFORMED NAME: Avidity NanoMedicines LLC DATE OF NAME CHANGE: 20140211 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-16 0 0001599901 Avidity Biosciences, Inc. RNA 0001181556 LEVIN ARTHUR A C/O AVIDITY BIOSCIENCES, INC. 10975 N. TORREY PINES ROAD, SUITE 150 LA JOLLA CA 92037 0 1 0 0 Chief Scientific Officer Common Stock 2021-03-05 5 G 0 E 37022 0.00 D 273872 I By family trust Common Stock 2021-03-05 5 G 0 E 37022 0.00 A 37022 I By charitable remainder trust Common Stock 2021-03-16 4 M 0 2625 1.24 A 2625 D Common Stock 2021-03-16 4 M 0 1975 0.53 A 4600 D Common Stock 2021-03-16 4 S 0 4600 27.8655 D 0 D Stock Option (Right to Buy) 1.24 2021-03-16 4 M 0 2625 0.00 D 2030-02-18 Common Stock 2625 208483 D Stock Option (Right to Buy) 0.53 2021-03-16 4 M 0 1975 0.00 D 2027-08-28 Common Stock 1975 45430 D The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.8571 to $27.8739. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter. This option is exercisable as to vested and unvested shares. The option was granted on August 29, 2017 and 1/48th of the shares subject to the option vest monthly. /s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact 2021-03-18